|
Michael Mulqueen brings to Synosia knowledge of business development and alliance management, along with a scientific background. Most recently, he was global head of alliances at Roche and a member of several senior decision-making bodies within Roche.
From 1988 to 2001, Michael worked in the Roche United Kingdom research group on both anti-inflammatory and anti-viral projects and was actively involved in managing several key relationships with external partners. Prior to joining Roche, he worked for seven years in the inflammation research unit at Rhone Poulenc Rorer.
He holds a bachelor's degree in pharmacology from the University of Liverpool, England. | 